Search

Access to Healthcare Strategy Sustainable Access Models

Boehringer Ingelheim aspires to be a leader in ensuring improved access by delivering more health to humans, animals and communities around the world. Read more about our holistic approach, based on partnerships and local empowerment.

GPP Interview with Professor Barker

An interview with Prof. Barker about generalized pustular psoriasis, its burden on patients and how patient outcomes can be improved

Striving to revolutionize mental health research

World Mental Health Day: Through a precision psychiatry approach and rich pipeline, we are committed to transforming the mental health landscape.

Retinal health: All eyes on vision loss

Discover how we want to prevent vision loss caused by diabetic retinopathy and other retinal diseases

Investing in our people University of Medicine Excellence

Almost one thousand of our employees have graduated from a program developed together with Harvard Medical School’s Executive Education.

Ethics and Compliance

Consistent with the Core of our Leitbild and Code of Conduct, we act with integrity and are committed to conducting business in a lawful and ethical manner.

Microbial Manufacturing Platform for Non-Platform Proteins

Depression

Lothar Halmer

Dr. Lothar Halmer is Chief Quality Officer and leads the Global Quality Organization in providing quality products for our patients every day.

Closing healthcare gaps with continued vaccination campaigns

How we continue combating rabies through collaborative efforts and the use of drone delivery in rural Kenya.

Our evolved employer value proposition

Find out from a father-daughter duo how we live up to our people promise and how our company identifies itself and differentiates from other employers.

U.S. FDA grants priority review for spesolimab in GPP

U.S. FDA grants priority review for spesolimab in the treatment of patients with generalized pustular psoriasis

Introducing CIAS

Schizophrenia affects 1 in 100, yet the condition can be misunderstood due to some symptoms being overlooked, such as cognitive impairment

Ezabenlimab

Ezabenlimab, PD-1 antibody

Central Nervous System Diseases

Find out more about our research and development in central nervous system diseases

Diabetes

Across Cancer Types

Rahul Prasad

Rahul J. Prasad is a Senior Consultant with our Corporate Strategy & Consulting division – a job that suits his passion for data and his love of variety.

Pride Month and our culture of respect

Watch our colleagues from the LGBTQIA+ community and allies share their views.

EMPRISE

Learn about the EMPRISE real-world evidence study and use of empagliflozin in routine clinical care

Zoonotic diseases things you should know

Zoonotic diseases can be transmitted between animals and humans. They are more common than you may think – and they are on the rise. Find out how this affects you.

TCO patient podcasts

From clinical trials to living with cancer, hear patient perspectives on different cancer topics in this podcast series.

Artrial Fibrillation

GPP

LastMile – improving through digital

LastMile initiative is an integrated, solutions-driven program seeking to make animal medical resources available in hard-to-reach areas in Africa.

About Us

Human Health

Animal Health

Science & Innovation

Partnering

Careers